Boston Scientific (BSX) FCF Payout Ratio Growth (1y) (2021 - 2023)
Powered by 
Analysis
Boston Scientific (BSX) FCF Payout Ratio Growth (1y) (2021 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -16.90% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -54.18% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -8.00% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 27.54% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | -18.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -60.78% |
| Mar 31, 2023 | 326.58% |
| Dec 31, 2022 | -64.37% |
| Sep 30, 2022 | 11.87% |
| Jun 30, 2022 | 165.84% |
| Mar 31, 2022 | -216.76% |
| Dec 31, 2021 | 125.13% |
| Sep 30, 2021 | 65.92% |